Gret-39

Current biomarkers (fasting glucose, HOMA-IR) detect disease only after significant pathology has developed. GRET-39 may rise years before clinical hyperglycemia. A 2023 retrospective cohort study found that individuals in the highest quartile of baseline plasma GRET-39 were to develop type 2 diabetes within 5 years, independent of BMI and age.

: The report examines how "popular practices" and innovative local systems can be integrated into formal development strategies. Participatory Practice GRET-39

Developing a story around GRET-39 typically follows a classic superhero or "kaiju" (giant monster) structure. Here is a story concept developed around that theme: Current biomarkers (fasting glucose